Sodium Hydroxide → HCID 53772361, 화합물
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][CH2:12][CH:13]([C:20]2[CH:33]=[CH:32][C:23]([CH:24]=[C:25]([CH3:31])[C:26]([O:28]CC)=[O:27])=[CH:22][CH:21]=2)[C:14]2[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=2)(=[O:10])=[O:9])=[CH:4][CH:3]=1.[OH-].[Na+]>CO>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][CH2:12][CH:13]([C:20]2[CH:21]=[CH:22][C:23]([CH:24]=[C:25]([CH3:31])[C:26]([OH:28])=[O:27])=[CH:32][CH:33]=2)[C:14]2[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=2)(=[O:10])=[O:9])=[CH:4][CH:3]=1참가 물질
4
실험 절차
Ethyl 4-[2-(4-chlorobenzenesulfonamido)-1-(3-pyridyl)ethyl]-α-methylcinnamate (6.8 mg) was dissolved in 1 ml of methanol, followed by addition of 0.2 ml of aqueous 2N sodium hydroxide solution, and refluxed for 18 hours. The solvent was distilled off under reduced pressure. The crystalline deposited through neutralization of the resulting mixture with 2N hydrogen chloride was filtered, to obtain 6.4 mg of 4-[2-(4-chlorobenzenesulfonamido)-1-(3-pyridyl)ethyl]-α-methylcinnamic acid. The spectrometric data thereof supports the structural formula of [49] as follows.